InvestorsHub Logo
Followers 21
Posts 1596
Boards Moderated 1
Alias Born 09/16/2008

Re: manny t post# 108

Tuesday, 05/31/2011 5:25:17 PM

Tuesday, May 31, 2011 5:25:17 PM

Post# of 164
Recently there have been THREE insider purchases from the CEO, VP, and Director of BioMimetics. This is a great sign! I believe BMTI can easily gap back to the $13 - $14 range. Probably more once Augment gets FDA approval, and more details of future products in the pipeline emerge. BMTI is a very likely takeover / merger / acquisition candidate by the lager pharmaceutical players in the industry, imo.